DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity

[1]  S. Thorgeirsson,et al.  Gene structure, tissue expression, and linkage mapping of the mouse DLC-1 gene (Arhgap7). , 2002, Gene.

[2]  L. Van Aelst,et al.  The role of Rho GTPases in disease development. , 2002, Gene.

[3]  R. Siebert,et al.  Loss of a novel tumor suppressor gene locus at chromosome 8p is associated with leukemic mantle cell lymphoma. , 2001, Blood.

[4]  L. Qin,et al.  Chromosome 8p deletion is associated with metastasis of human hepatocellular carcinoma when high and low metastatic models are compared , 2001, Journal of Cancer Research and Clinical Oncology.

[5]  J. Carpten,et al.  Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23. , 2001, American journal of human genetics.

[6]  A. C. Chinault,et al.  Functional identification of LZTS1 as a candidate prostate tumor suppressor gene on human chromosome 8p22 , 2001, Oncogene.

[7]  K. Arden,et al.  p190-A, a human tumor suppressor gene, maps to the chromosomal region 19q13.3 that is reportedly deleted in some gliomas. , 2000, Gene.

[8]  U. Jaeger,et al.  The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. Zimonjic,et al.  Assignment1 and cloning of mouse Arhgap7 to chromosome 8A4–B2, a conserved syntenic region of human chromosome 8p22→p21 , 2000, Cytogenetic and Genome Research.

[10]  Z. Arbieva,et al.  High-resolution physical map and transcript identification of a prostate cancer deletion interval on 8p22. , 2000, Genome research.

[11]  Y. Emori,et al.  Morphological Changes and Detachment of Adherent Cells Induced by p122, a GTPase-activating Protein for Rho* , 1999, The Journal of Biological Chemistry.

[12]  C. Ponting,et al.  START: a lipid-binding domain in StAR, HD-ZIP and signalling proteins. , 1999, Trends in biochemical sciences.

[13]  J Isola,et al.  Molecular cytogenetics of primary breast cancer by CGH , 1998, Genes, chromosomes & cancer.

[14]  F. Matsumura,et al.  Small GTP-binding Protein Rho Stimulates the Actomyosin System, Leading to Invasion of Tumor Cells* , 1998, The Journal of Biological Chemistry.

[15]  E. Bergstralh,et al.  Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer , 1998, Genes, chromosomes & cancer.

[16]  M. Werner,et al.  Comparative genomic hybridisation for the analysis of chromosomal imbalances in solid tumours and haematological malignancies , 1997, Histochemistry and Cell Biology.

[17]  Y. Emori,et al.  A dual functional signal mediator showing RhoGAP and phospholipase C‐delta stimulating activities. , 1995, The EMBO journal.

[18]  A. Hall,et al.  Rho GTPases in transformation and metastasis. , 2002, Advances in cancer research.